Free Press Release

FaceBook Page Twitter Feed
You are here: Home > Exclusive News > Health Point Inc. A Step Closer To Ischemia Treatment

Health Point Inc. A Step Closer To Ischemia Treatment

Posted Jan 9, 2014 by reginaldanderson
Health Point Inc. recently announced a small but important advance towards treatment of chronic lower limb ischemia.

FOR IMMEDIATE RELEASE (Press Release) Jan 9, 2014 -- Through the companies' advancements in promoting angiogenesis within a laboratory setting, Health Point Inc. can now cause stem cells to produce and stimulate new capillaries. The clinical treatment approach would have the modified stem cells transplanted locally.

By increasing research funding for the study of mesenchymal stem cells from bone marrow, the company expects to learn crucial information about their immune modulatory properties. Future research facility expansion is expected to be funded by an initial public offering (IPO) which has been announced for mid-2014. More information will be released as it is made available through releases and the company website.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this item is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at and other sources before making any material decisions.
-- EOF ---
Contact Email :
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong Kong
Country : China
Categories : Business, Health, Research
Tags : health, Stem Cells, Research, Manufacture, Supply
Last Updated : Jan 9, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore